InDex Pharmaceuticals is a Swedish biotechnology company developing immunomodulatory therapies for inflammatory diseases. Its lead drug candidate, cobitolimod, has been…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see InDex Pharmaceuticals →Already a subscriber? Sign in
Xcout Intel tracks InDex Pharmaceuticals continuously — this profile deepens as new filings, funding, people and hiring data arrive.